| Title | Recent Advances in CRISPR‑Cas Technologies for Synthetic Biology |
|---|---|
| Author | Song Hee Jeong, Ho Joung Lee, and Sang Jun Lee* |
| Address | Department of Systems Biotechnology, Chung-Ang University, Anseong 17546, Republic of Korea |
| Bibliography | Journal of Microbiology, 61(1),13-36, 2023, |
| DOI | 10.1007/s12275-022-00005-5 |
| Key Words | CRISPR-Cas technologies · Synthetic biology · Microbiology |
| Abstract | With developments in synthetic biology, “engineering biology” has emerged through standardization and platformization based on hierarchical, orthogonal, and modularized biological systems. Genome engineering is necessary to manufacture and design synthetic cells with desired functions by using bioparts obtained from sequence databases. Among various tools, the CRISPR-Cas system is modularly composed of guide RNA and Cas nuclease; therefore, it is convenient for editing the genome freely. Recently, various strategies have been developed to accurately edit the genome at a single nucleotide level. Furthermore, CRISPR-Cas technology has been extended to molecular diagnostics for nucleic acids and detection of pathogens, including disease-causing viruses. Moreover, CRISPR technology, which can precisely control the expression of specific genes in cells, is evolving to find the target of metabolic biotechnology. In this review, we summarize the status of various CRISPR technologies that can be applied to synthetic biology and discuss the development of synthetic biology combined with CRISPR technology in microbiology. |